Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu A Karpov

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Kardiologiia|February 23, 2016
[Study TRIUMVIRATE: Reducing the Risk of Cardiovascular Events in Hypertensive Patients Using Triple Combination Antihypertensive and Lipid-Lowering Drugs]Yu A Karpov
Kardiologiia|December 21, 2002
[FLAG--a program of achievability of target blood pressure levels during treatment of patients with hypertension with fosinopril]Yu A Karpov,
Kardiologiia|March 15, 2017
[Prevalence of Hypertriglyceridemia: New Data Across the Russian Population. The PROMETHEUS Study]Yu A Karpov On Behalf Of Participants Of The Prometheus Study
Kardiologiia|December 19, 2019
[Gerontology Issues in Cardiology Practice]O N Tkacheva, Yu N Belenkov, Yu A Karpov, et al.
Kardiologiia|March 16, 2017
[Inflammatory Markers and Their Role in Assessing Prognosis of Patients With Stable Coronary Artery Disease After Coronary Stenting]D I Tomilova, F F Byazrova, V V Lopukhova, et al.
Kardiologiia|April 30, 2016
[Inflammatory Markers and Their RoIe in Assessing Prognosis of patients With Stable Coronary Artery Disease After Coronary Stenting]D I Tomilova, F F Byazrova, V V Lopukhova, et al.
Kardiologiia|March 16, 2017
[Study TRIUMVIRATE: Reducing the Risk of Cardiovascular Events in Hypertensive Patients Using Triple Combination Antihypertensive and Lipid-Lowering Drugs]Yu A Karpov On Behalf Of The Research Team Of The Russian Part Of The Study
Kardiologiia|March 15, 2017
[Cardiovascular Complications of Rheumatoid Arthritis: Prevalence and Pathogenesis]L B Krougly, O A Fomicheva, Yu A Karpov, et al.
Kardiologiia|December 21, 2002
[Angiotensin II receptor blocker telmisartan: effect on 24-hour blood pressure profile and left ventricular hypertrophy in patients with hypertension]O V Ivanova, O A Fomicheva, L M Sergakova, et al.
Terapevticheskii Arkhiv|November 24, 2015
[Heat and cardiovascular diseases: A review of epidemiological surveys]I L Kozlovskaya, O S Bulkina, V V Lopukhova, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Kardiologiia|February 23, 2016
[Study TRIUMVIRATE: Reducing the Risk of Cardiovascular Events in Hypertensive Patients Using Triple Combination Antihypertensive and Lipid-Lowering Drugs]Yu A Karpov
Kardiologiia|December 21, 2002
[FLAG--a program of achievability of target blood pressure levels during treatment of patients with hypertension with fosinopril]Yu A Karpov,
Kardiologiia|March 15, 2017
[Prevalence of Hypertriglyceridemia: New Data Across the Russian Population. The PROMETHEUS Study]Yu A Karpov On Behalf Of Participants Of The Prometheus Study
Kardiologiia|December 19, 2019
[Gerontology Issues in Cardiology Practice]O N Tkacheva, Yu N Belenkov, Yu A Karpov, et al.
Kardiologiia|March 16, 2017
[Inflammatory Markers and Their Role in Assessing Prognosis of Patients With Stable Coronary Artery Disease After Coronary Stenting]D I Tomilova, F F Byazrova, V V Lopukhova, et al.
Kardiologiia|April 30, 2016
[Inflammatory Markers and Their RoIe in Assessing Prognosis of patients With Stable Coronary Artery Disease After Coronary Stenting]D I Tomilova, F F Byazrova, V V Lopukhova, et al.
Kardiologiia|March 16, 2017
[Study TRIUMVIRATE: Reducing the Risk of Cardiovascular Events in Hypertensive Patients Using Triple Combination Antihypertensive and Lipid-Lowering Drugs]Yu A Karpov On Behalf Of The Research Team Of The Russian Part Of The Study
Kardiologiia|March 15, 2017
[Cardiovascular Complications of Rheumatoid Arthritis: Prevalence and Pathogenesis]L B Krougly, O A Fomicheva, Yu A Karpov, et al.
Kardiologiia|December 21, 2002
[Angiotensin II receptor blocker telmisartan: effect on 24-hour blood pressure profile and left ventricular hypertrophy in patients with hypertension]O V Ivanova, O A Fomicheva, L M Sergakova, et al.
Terapevticheskii Arkhiv|November 24, 2015
[Heat and cardiovascular diseases: A review of epidemiological surveys]I L Kozlovskaya, O S Bulkina, V V Lopukhova, et al.
Pageof 2